Fayez Sarofim & Company Trimmed Its Abbottlaboratories (ABT) Holding by $14.76 Million; Vulcan Value Partners Has Lowered Position in Aci Worldwide (ACIW) by $16.92 Million

April 24, 2018 - By Adrian Erickson

ACI Worldwide, Inc. (NASDAQ:ACIW) Logo

Vulcan Value Partners Llc decreased its stake in Aci Worldwide Inc (ACIW) by 10.73% based on its latest 2017Q4 regulatory filing with the SEC. Vulcan Value Partners Llc sold 768,991 shares as the company’s stock rose 5.97% while stock markets declined. The institutional investor held 6.40 million shares of the technology company at the end of 2017Q4, valued at $145.05 million, down from 7.17M at the end of the previous reported quarter. Vulcan Value Partners Llc who had been investing in Aci Worldwide Inc for a number of months, seems to be less bullish one the $2.79 billion market cap company. The stock decreased 1.43% or $0.35 during the last trading session, reaching $24.07. About 110,069 shares traded. ACI Worldwide, Inc. (NASDAQ:ACIW) has risen 10.81% since April 24, 2017 and is uptrending. It has underperformed by 0.74% the S&P500.

Fayez Sarofim & Company decreased its stake in Abbottlaboratories (ABT) by 6% based on its latest 2017Q4 regulatory filing with the SEC. Fayez Sarofim & Company sold 258,895 shares as the company’s stock rose 5.88% while stock markets declined. The institutional investor held 4.06M shares of the major pharmaceuticals company at the end of 2017Q4, valued at $231.51 million, down from 4.32 million at the end of the previous reported quarter. Fayez Sarofim & Company who had been investing in Abbottlaboratories for a number of months, seems to be less bullish one the $101.72 billion market cap company. The stock decreased 1.01% or $0.6 during the last trading session, reaching $58.24. About 3.04M shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since April 24, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Since December 11, 2017, it had 0 insider purchases, and 5 insider sales for $6.33 million activity. Shay John M Jr also sold $1.95M worth of ACI Worldwide, Inc. (NASDAQ:ACIW) shares. 90,000 ACI Worldwide, Inc. (NASDAQ:ACIW) shares with value of $2.02M were sold by MCGRODDY JAMES. SUWINSKI JAN sold $722,721 worth of stock.

Vulcan Value Partners Llc, which manages about $6.07B and $12.21 billion US Long portfolio, upped its stake in Mckesson Corp (NYSE:MCK) by 305,492 shares to 3.61M shares, valued at $563.35 million in 2017Q4, according to the filing. It also increased its holding in Axis Capital Holdings Ltd (NYSE:AXS) by 953,525 shares in the quarter, for a total of 7.65 million shares, and has risen its stake in Cardinal Health Inc (NYSE:CAH).

Among 6 analysts covering ACI Worldwide (NASDAQ:ACIW), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. ACI Worldwide had 8 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was initiated by Monness Crespi & Hardt with “Buy” on Wednesday, June 15. The stock has “Buy” rating by Raymond James on Thursday, August 31. On Friday, February 23 the stock rating was maintained by Stephens with “Buy”. On Tuesday, August 4 the stock rating was downgraded by Zacks to “Buy”. Monness Crespi & Hardt maintained the stock with “Buy” rating in Friday, November 4 report. The rating was initiated by Credit Suisse with “Neutral” on Friday, December 11. The company was maintained on Friday, February 26 by Avondale.

Analysts await ACI Worldwide, Inc. (NASDAQ:ACIW) to report earnings on May, 3. They expect $-0.11 EPS, down 650.00% or $0.13 from last year’s $0.02 per share. After $0.64 actual EPS reported by ACI Worldwide, Inc. for the previous quarter, Wall Street now forecasts -117.19% negative EPS growth.

Investors sentiment decreased to 1.29 in Q4 2017. Its down 0.49, from 1.78 in 2017Q3. It dived, as 11 investors sold ACIW shares while 61 reduced holdings. 24 funds opened positions while 69 raised stakes. 116.79 million shares or 1.64% less from 118.75 million shares in 2017Q3 were reported. Connable Office Incorporated has 0.04% invested in ACI Worldwide, Inc. (NASDAQ:ACIW). Goldman Sachs Inc owns 611,713 shares for 0% of their portfolio. Mutual Of America Mngmt Limited Liability Company holds 0.03% of its portfolio in ACI Worldwide, Inc. (NASDAQ:ACIW) for 95,858 shares. Ironwood Inv Management Ltd Limited Liability Company holds 0.67% or 41,145 shares in its portfolio. Schwab Charles Inc holds 0.01% in ACI Worldwide, Inc. (NASDAQ:ACIW) or 680,055 shares. Hsbc Public Limited Company, a United Kingdom-based fund reported 9,599 shares. Guggenheim Capital Limited Liability Corp has invested 0% in ACI Worldwide, Inc. (NASDAQ:ACIW). Eagle Boston Mngmt Inc stated it has 364,271 shares. King Luther Capital Mngmt Corp invested in 0.15% or 829,770 shares. California State Teachers Retirement Sys has 183,825 shares for 0.01% of their portfolio. Northern Tru Corporation holds 0.01% of its portfolio in ACI Worldwide, Inc. (NASDAQ:ACIW) for 1.88M shares. Old Savings Bank In invested in 16,092 shares or 0.02% of the stock. Vanguard Gru Inc has 0.01% invested in ACI Worldwide, Inc. (NASDAQ:ACIW). Tygh stated it has 0.93% of its portfolio in ACI Worldwide, Inc. (NASDAQ:ACIW). Legal And General Gru Public Ltd, a United Kingdom-based fund reported 104,747 shares.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 106 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Abbott Laboratories (NYSE:ABT) has “Neutral” rating given on Tuesday, January 30 by Citigroup. The firm has “Hold” rating given on Thursday, September 28 by Northland Capital. Credit Suisse reinitiated the stock with “Outperform” rating in Monday, August 10 report. The stock of Abbott Laboratories (NYSE:ABT) has “Overweight” rating given on Thursday, April 20 by Barclays Capital. On Tuesday, September 22 the stock rating was initiated by UBS with “Neutral”. BTIG Research downgraded the shares of ABT in report on Monday, January 22 to “Neutral” rating. The firm has “Buy” rating by Jefferies given on Thursday, August 4. The stock of Abbott Laboratories (NYSE:ABT) has “Overweight” rating given on Thursday, January 25 by JP Morgan. BMO Capital Markets maintained it with “Hold” rating and $5300 target in Thursday, July 20 report. As per Thursday, October 19, the company rating was maintained by Citigroup.

Fayez Sarofim & Company, which manages about $31.66 billion and $19.30 billion US Long portfolio, upped its stake in Wynnresortsltd. (NASDAQ:WYNN) by 6,000 shares to 21,000 shares, valued at $3.54 million in 2017Q4, according to the filing. It also increased its holding in Spdrs&P500etftrust (SPY) by 1,578 shares in the quarter, for a total of 2,454 shares, and has risen its stake in Southwestairlinesco (NYSE:LUV).

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts